Richmond Pharmacology is delighted to confirm our participation in BIO International Convention 2025 in Boston, the premier global event for biotechnology, attracting innovators and industry leaders from around the world.
With thousands of professionals expected to attend, this year’s convention will emphasize breakthroughs in therapeutic discovery, cutting-edge technologies, and global clinical collaboration.
Representing Richmond Pharmacology at BIO International Convention:
● Dr. Jörg Täubel, Chief Executive Officer
● Dr Lisa Campbell, Director of Regulatory Strategy
● Stephen Wilkinson, Business Development Manager
● Amina Senoussi, Key Account Executive
Our team is excited to connect with biotech innovators and trial sponsors to explore opportunities in:
● Gene editing and RNA-based therapies
● Rare and ultra-rare disease research
● Innovative regulatory pathways
● Bridging studies
● Patient-centric clinical trial delivery
Whether you're advancing a groundbreaking therapy or expanding into new markets, we invite you to meet us at Booth 765 in the Exhibit Hall to discover how Richmond Pharmacology can help achieve your clinical development objectives.
For meeting requests or collaborationinquiries, please contact:
📧 s.wilkinson@richmondpharmacology.com
Learn more about the event
.svg){kind=small}
-min.jpg)
.jpg)
